These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31725475)

  • 21. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dexamethasone and hydrocortisone on rocuroniuminduced neuromuscular blockade and reversal by sugammadex in phrenic nerve-hemidiaphragm rat model.
    Choi H; Park SY; Kim YB; In J; Yang HS; Lee JS; Kim S; Park S
    Korean J Anesthesiol; 2019 Aug; 72(4):366-374. PubMed ID: 30886132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block.
    Groudine SB; Soto R; Lien C; Drover D; Roberts K
    Anesth Analg; 2007 Mar; 104(3):555-62. PubMed ID: 17312208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone concentration affecting rocuronium-induced neuromuscular blockade and sugammadex reversal in a rat phrenic nerve-hemidiaphragm model: An ex vivo study.
    In J; Bae H; Choi H; Kim YB; Lee S; Yang HS
    Eur J Anaesthesiol; 2018 Nov; 35(11):856-862. PubMed ID: 30045055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.
    Abd El-Rahman AM; Othman AH; El Sherif FA; Mostafa MF; Taha O
    Minerva Anestesiol; 2017 Feb; 83(2):138-144. PubMed ID: 27575450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
    Donati F
    Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of Deep Pipecuronium-Induced Neuromuscular Block With Moderate Versus Standard Dose of Sugammadex: A Randomized, Double-Blind, Noninferiority Trial.
    Tassonyi E; Asztalos L; Szabó-Maák Z; Nemes R; Pongrácz A; Lengyel S; Fülesdi B
    Anesth Analg; 2018 Dec; 127(6):1344-1350. PubMed ID: 30169407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery.
    Fujita A; Ishibe N; Yoshihara T; Ohashi J; Makino H; Ikeda M; Setoguchi H
    Acta Anaesthesiol Taiwan; 2014 Jun; 52(2):54-8. PubMed ID: 25016508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients.
    Silva MPD; Matsui C; Kim DD; Vieira JE; Malheiros CA; Mathias LAST
    Rev Col Bras Cir; 2017; 44(1):41-45. PubMed ID: 28489210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.
    Lu IC; Wu CW; Chang PY; Chen HY; Tseng KY; Randolph GW; Cheng KI; Chiang FY
    Laryngoscope; 2016 Apr; 126(4):1014-9. PubMed ID: 26748952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.
    Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW
    Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study.
    Söderström CM; Borregaard Medici R; Assadzadeh S; Følsgaard S; Rosenberg J; Gätke MR; Madsen MV
    Eur J Anaesthesiol; 2018 Nov; 35(11):876-882. PubMed ID: 29878947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.